Fig. 3From: Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progressionKaplan-Meier plots suggest that patients with high expression of (A) AKT1; (B) MDM2; and (C) high expression of AKT1 and MDM2 together have the worst clinical outcomesBack to article page